Skip to content
Open access

Insomnia symptoms and stress exposure interact in relation to Alzheimer’s disease biomarkers

Sep 2026 · Journal of Neurology · Vol 273 · 0 citations · 66 references
Medicine

TL;DR

It is suggested that chronic stress and sleep disturbances exhibit an interactive relationship in their associations with AD pathology, and the need for further research into interactive effects of multiple modifiable risk factors in the development of AD is highlighted.

Abstract

Several modifiable factors affect Alzheimer’s disease (AD) risk. However, evidence on how these factors interact remains scarce, limiting our understanding of their role in AD development. This study aims to assess interactions between chronic stress exposure and insomnia in relation to AD biomarkers beta-amyloid (Aβ42), total tau, and phosphorylated tau. The present study included 124 memory clinic patients without dementia from the Cortisol and Stress in Alzheimer’s disease (Co-STAR) cohort study. Insomnia symptoms, stressful life events (SLEs) and current perceived stress were self-reported via questionnaires, while AD biomarkers were assessed from the cerebrospinal fluid (CSF). Cross-sectional interactions between stress and insomnia in relation to AD biomarkers were examined using linear regression models. Insomnia and SLEs interacted in relation to Aβ42. Greater stressor exposure was associated with reduced CSF Aβ42 levels, reflecting greater brain amyloid accumulation, only in those with moderate-to-high insomnia scores. No interactions were found for total or phosphorylated tau. This study suggests that chronic stress and sleep disturbances exhibit an interactive relationship in their associations with AD pathology, and highlights the need for further research into interactive effects of multiple modifiable risk factors in the development of AD.

Read PDF

Similar papers

Review Open access Aug 2026

Association between habitual sleep duration and Alzheimer’s disease

This study clarifies the effectiveness of sleep time as a predictive tool for AD and underscores its importance in AD assessment, and advocates incorporating body composition factors into AD risk assessment, thus expanding the scope of Alzheimer’s disease prevention strategies.

Guang Yang, Wen-Zhe Hou, Jia-Wen Wu et al. · 0 citations
Review Open access Oct 2026

Sleep Loss and Alzheimer’s Disease: Mechanisms, Risk Factors, and Cognitive Consequences—A Narrative Review

Although current evidence does not establish that sleep interventions alone can prevent AD, sleep health should be regarded as an important component of brain health, early risk assessment, and dementia risk reduction.

Antoniya Hachmeriyan, G. Panayotova, A. Anand et al. · 0 citations
Open access Sep 2026

Health-related factors and their impact on blood-based biomarkers of Alzheimer's disease

In CSF-confirmed participants, age emerged as the most consistent predictor of plasma biomarker levels, particularly NFL and pTau181, which suggests that plasma biomarkers are influenced primarily by age and genetic background rather than by metabolic factors in this cohort.

Carolin I. Kurz, Marleen Taute, Paulina Tegethoff et al. · 0 citations
Open access Sep 2026

Linking behavioral and psychological symptoms to nutritional status in Alzheimer's disease: Clinical correlations and implications.

It was revealed that poorer nutritional status, particularly lower MNA scores and lower prealbumin levels, was associated with higher likelihood of BPSD, which may help identify at-risk patients and inform therapeutic strategies.

Wen-Jing Nie, Zhen-Tao Liang, Qing-Rong Fu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.